This page shows you your search results in order of date. This is page number 19.

Order by Relevance | Date

Total 71574 results found since Jan 2013.

Effect of Probiotic Supplements on Metabolic Control of People With Type 2 Diabetes Mellitus in Greece
Condition:   Diabetes Mellitus, Type 2 Intervention:   Dietary Supplement: LactoLevure Sponsors:   Konstantinos Makrilakis, MD;   Uni-Pharma Enrolling by invitation
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua
Conditions:   Malaria,Falciparum;   Malaria, Vivax;   Malaria;   Infections;   Uncomplicated Malaria;   Uncomplicated Plasmodium Falciparum Interventions:   Drug: Dihydroartemisinin;   Drug: Piperaquine;   Drug: Primaquine;   Other: Momordica Charantia Extract Sponsors:   Syamsudin Abdillah,Ph.D, Pharm D;   Cipto Mangunkusumo Hospital;   PT Natura Nuswantara Nirmala Completed
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Effect of Probiotic Supplements on Metabolic Control of People With Type 2 Diabetes Mellitus in Greece
Condition:   Diabetes Mellitus, Type 2 Intervention:   Dietary Supplement: LactoLevure Sponsors:   Konstantinos Makrilakis, MD;   Uni-Pharma Enrolling by invitation
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Phase 1 Dose Escalation Study for VIP943 Subjects With Advanced CD123+ Hematologic Malignancies
Conditions:   Acute Myeloid Leukemia;   B-cell Acute Lymphoblastic Leukemia;   High-risk Myelodysplastic Syndrome Intervention:   Drug: VIP943 Sponsor:   Vincerx Pharma, Inc. Not yet recruiting
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua
Conditions:   Malaria,Falciparum;   Malaria, Vivax;   Malaria;   Infections;   Uncomplicated Malaria;   Uncomplicated Plasmodium Falciparum Interventions:   Drug: Dihydroartemisinin;   Drug: Piperaquine;   Drug: Primaquine;   Other: Momordica Charantia Extract Sponsors:   Syamsudin Abdillah,Ph.D, Pharm D;   Cipto Mangunkusumo Hospital;   PT Natura Nuswantara Nirmala Completed
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Testosterone Therapy Tied to Better Mental Health
WEDNESDAY, Sept. 13, 2023 -- Testosterone therapy significantly decreases gender dysphoria, depression, and suicidality in transgender and gender-diverse individuals desiring testosterone therapy, according to a study published online Sept. 7 in...
Source: Drugs.com - Pharma News - September 13, 2023 Category: Pharmaceuticals Source Type: news

Cardiac Arrest Survival Lower at EMS Agencies Serving Minority Populations
WEDNESDAY, Sept. 13, 2023 -- Risk-standardized survival rates for out-of-hospital cardiac arrest (OHCA) are lower for emergency medical service (EMS) agencies working in Black and Hispanic catchment areas than those in White catchment areas,...
Source: Drugs.com - Pharma News - September 13, 2023 Category: Pharmaceuticals Source Type: news

Hypertension While Lying Down Tied to Worse Cardiovascular Disease Outcomes
WEDNESDAY, Sept. 13, 2023 -- Having hypertension while in a supine position is associated with a higher risk for cardiovascular disease (CVD), CVD-related events, and death, according to a study presented at the American Heart Association...
Source: Drugs.com - Pharma News - September 13, 2023 Category: Pharmaceuticals Source Type: news

Risk for Dementia Reduced in Association With Antihypertensive Use
WEDNESDAY, Sept. 13, 2023 -- Antihypertensive use is associated with a reduced risk for dementia compared with untreated hypertension, according to research published online Sept. 12 in JAMA Network Open. Matthew J. Lennon, M.D., from the...
Source: Drugs.com - Pharma News - September 13, 2023 Category: Pharmaceuticals Source Type: news

New COVID-19 Booster Shots Given Support by CDC
WEDNESDAY, Sept. 13, 2023 -- Following an approval granted Monday by the U.S. Food and Drug Administration, an expert panel from the U.S. Centers for Disease Control and Prevention on Tuesday also signed off on new COVID-19 boosters for...
Source: Drugs.com - Pharma News - September 13, 2023 Category: Pharmaceuticals Source Type: news

Whites Have Greatest Magnitude of Association of Socioeconomic Status With LE8
WEDNESDAY, Sept. 13, 2023 -- The magnitude of association of socioeconomic status (SES) with the American Heart Association Life ' s Essential 8 (LE8) is greatest among non-Hispanic White Americans (NHWA), according to a study published online Sept....
Source: Drugs.com - Pharma News - September 13, 2023 Category: Pharmaceuticals Source Type: news

Receipt of PT, Chiropractic Care Reportedly Low for Comorbid Chronic LBP, Opioid Use Disorder
WEDNESDAY, Sept. 13, 2023 -- For Medicare beneficiaries with chronic low back pain (CLBP) and opioid use disorder (OUD), receipt of physical therapy (PT) and chiropractic care is low overall and lower for racial and ethnic minority groups, according...
Source: Drugs.com - Pharma News - September 13, 2023 Category: Pharmaceuticals Source Type: news